Crinetics Pharmaceuticals CRNX Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Crinetics Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:ShortTermInvestments.
The official record: Crinetics Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Crinetics Pharmaceuticals's short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Crinetics Pharmaceuticals's short-term investments?
- Crinetics Pharmaceuticals (CRNX) reported short-term investments of $1.18B in Q1 2026.
- How has Crinetics Pharmaceuticals's short-term investments changed year-over-year?
- Crinetics Pharmaceuticals's short-term investments decreased by 0.2% year-over-year, from $1.18B to $1.18B.
- What is the long-term trend for Crinetics Pharmaceuticals's short-term investments?
- Over 5 years (2020 to 2025), Crinetics Pharmaceuticals's short-term investments has grown at a 64.1% compound annual growth rate (CAGR), from $77.79M to $926.35M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.